Viewing Study NCT06591520


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2026-02-17 @ 5:04 PM
Study NCT ID: NCT06591520
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer
Sponsor: Akeso
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Cancer View
Keywords: